Reply to Letter: "Rationale for Heating Oxaliplatin for the Intraperitoneal Treatment of Peritoneal Carcinomatosis"

Ann Surg. 2016 Apr;263(4):e60-1. doi: 10.1097/SLA.0000000000001027.

Authors

Lucas Sideris¹, Pierre Drolet, Andrew Mitchell, Pierre Dubé

Affiliation

¹ Department of Surgery, Maisonneuve-Rosemont Hospital, University of Montreal, Montréal, Quebec, Canada Department of Anesthesiology, Maisonneuve-Rosemont Hospital, University of Montreal, Montreal, Quebec, Canada Department of Pathology, Maisonneuve-Rosemont Hospital, University of Montreal, Montreal, Quebec, Canada Department of Surgery, Maisonneuve-Rosemont Hospital, University of Montreal, Montreal, Quebec, Canada.

PMID: 26636241
DOI: 10.1097/SLA.0000000000001027

No abstract available

Publication types

Letter
Comment

MeSH terms

Animals
Antineoplastic Agents / administration & dosage*
Antineoplastic Agents / pharmacokinetics*
Carcinoma / drug therapy*
Carcinoma / metabolism*
Hot Temperature*
Male
Organoplatinum Compounds / administration & dosage*
Organoplatinum Compounds / pharmacokinetics*
Peritoneal Neoplasms / drug therapy*
Peritoneal Neoplasms / metabolism*

Substances

Antineoplastic Agents
Organoplatinum Compounds